The evolution of ICER’s review process for new medical interventions and a critical review of economic evaluations (2018-2019): how stakeholders can collaborate with ICER to improv...

por Ronquest, Naoko A, Paret, Kyle, Gould, Ian Gopal, Barnett, Christine L, Mladsi, Deirdre M
Publicado 2021

A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney diseas...

por Mader, Gregory, Mladsi, Deirdre, Sanon, Myrlene, Purser, Molly, Barnett, Christine L., Oberdhan, Dorothee, Watnick, Terry, Seliger, Stephen
Publicado 2022